Furthermore, through analysis of TIM expression and stem cell-regulated gene signature via gene set enrichment analysis (GSEA) in published expression profiles from patients with breast cancer, we found that there was positive correlation between TIM levels in breast tumors and the embryonic stem cell core signature (Additional file 3: Figure S2A). This evidence concerns the gene TIMELESS and breast carcinoma.